| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.017 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0015 | 1 |